Off-label Use Articles

Off-label Use Articles:

Nursing Homes Poisoning Our Elderly

A new study published in the Archives of Internal Medicine shows that even a single dose of antipsychotic medication doubles the risk of a serious adverse event leading to hospitalization and/or death. These drugs are widely used as behavior management in nursing homes, have no FDA approval for this use, and are clearly very unsafe.

Read More: antipsychotic medication, elderly, FDA, off-label use

Psychiatric Credibility Takes a Major Nose Dive

The New York Times has just reported on the investigation by Senator Charles Grassley (R-Iowa) into the money paid by Big Pharma to the key researchers promoting the off label use of anti-psychotic medications. It shows that the researchers who have been behind promoting massive off-label use of these powerful drugs to children were on the take from Big Pharma and hiding millions in “consulting fees.”

Read More: anti-psychotic medications, FDA, Grassley, off-label use

How the FDA, Big Pharma, and Doctors Cause Injury for Profit

In some ways the health care in America is the finest in the world. In other ways it is a severe risk to health, even deadly. The dark side of this issue involves medication profits at the expense of human health. This questionable health care approach costs at least 200 billion dollars a year and involves the costs of the drugs themselves, the injuries they cause, and the appropriate law suits that follow. The perpetrators of this fraud are the pharmaceutical companies acting in tandem with the FDA, doctors paid under the table by Big Pharma, and gullible doctors willing to write off-label prescriptions based on the hype they hear from doctors on the take and Big Pharma sales reps.

Read More: atypical anti-psychotic medication, Big Pharma, health care, injuries and deaths, off-label use